My Brother's Keeper

My Brother's Keeper (MBK) is an Israeli pharmaceutical company focused on the development, research, and production of pharmaceutical-grade medical cannabis. The company is distinguished in the industry for its rigorous focus on product standardization, ensuring that its cannabis strains and formulations maintain high stability and chemical consistency across batches. MBK operates advanced cultivation and manufacturing facilities in Israel and maintains strategic research partnerships with leading institutions, such as Hadassah Medical Center, to validate its therapeutic offerings through clinical research. Its products are primarily designed to address chronic pain, PTSD, and oncology-related symptoms, aiming to provide medical professionals with a reliable and predictable plant-based treatment modality.